DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Hereditary Angioedema - Epidemiology Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Hereditary Angioedema - Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Hereditary Angioedema in seven major markets (US, France, Germany, Italy, Spain, UK and Japan).The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by a team of industry experts.

Key Coverage and Benefits:

The report includes the prevalent population and how will it change over the next eight years.Coverage of key Hereditary Angioedema sub-populations and its prevalent or incident casesPrevalent or incident cases segmented by age and sex.The key differences in epidemiology patterns across the seven market segments.

Key Topics Covered:

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary

Key Findings

4. Hereditary Angioedema Overview

Hereditary Angioedema DefinitionPathophysiologySymptomsEtiology

5. Risk Factors Associated with Hereditary Angioedema

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations

Key FindingsKey Sources used and Forecast MethodologyPrevalent Cases and Incident Cases-2015-2025Prevalent & Incident Cases by Category-2015-2025Age-Specific Prevalent/ Incident Cases of Hereditary AngioedemaSex-Specific Prevalent/Incident Cases of Hereditary AngioedemaDisease Type Specific Prevalent/Incident Cases of Hereditary Angioedema

8. Prevalent & Incident Cases by 7 MM-2015-2025

Hereditary Angioedema Epidemiology of United States-2025Hereditary Angioedema Epidemiology of United Kingdom-2025Hereditary Angioedema Epidemiology of Germany-2025Hereditary Angioedema Epidemiology of France-2025Hereditary Angioedema Epidemiology of Spain-2025Hereditary Angioedema Epidemiology of Italy-2025Hereditary Angioedema Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/j274d4/hereditary?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005439/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs,Immune Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 08:17 AM/DISC: 09/11/2018 08:17 AM